Search

Search results

93 results found

Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.

Ribeiro, Marcelle de Carvalho, Arvin Iracheta-Vellve, Mrigya Babuta, Charles D Calenda, Christopher Copeland, Yuan Zhuang, Patrick P Lowe, et al. 2023. “Alcohol-Induced Extracellular ASC Specks Perpetuate Liver Inflammation and Damage in Alcohol-Associated Hepatitis Even After Alcohol Cessation.”. Hepatology (Baltimore, Md.) 78 (1): 225-42.

A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis.

Tornai, David, Mack Mitchell, Craig J McClain, Srinivasan Dasarathy, Arthur McCullough, Svetlana Radaeva, Aimee Kroll-Desrosiers, JungAe Lee, Bruce Barton, and Gyongyi Szabo. 2023. “A Novel Score of IL-13 and Age Predicts 90-Day Mortality in Severe Alcohol-Associated Hepatitis: A Multicenter Plasma Biomarker Analysis.”. Hepatology Communications 7 (12).

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.

Tepper, Stewart J, David W Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, et al. 2025. “Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.”. European Journal of Neurology 32 (8): e70328.

Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.

Lucey, Michael Ronan, Gene Y Im, Jessica L Mellinger, Gyongyi Szabo, and David W Crabb. 2020. “Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.”. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 26 (1): 14-16.

Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Dasarathy, Srinivasan, Mack C Mitchell, Bruce Barton, Craig J McClain, Gyongyi Szabo, Laura E Nagy, Svetlana Radaeva, and Arthur J McCullough. 2020. “Design and Rationale of a Multicenter Defeat Alcoholic Steatohepatitis Trial: (DASH) Randomized Clinical Trial to Treat Alcohol-Associated Hepatitis.”. Contemporary Clinical Trials 96: 106094.